F.D.A. Allows First Use of a Novel Cancer Drug
This is very good news.. first we get access to a new class of drugs - PD-1 inhibitors. Next - the FDA showed that they understand the cancer community's needs and approved this after only a phase 1 trial. This could open the floodgates for FDA approval of new cancer treatments as there are a few brain cancer treatments in the pipeline that will soon be reporting phase 2 results. IF the results are good enough, perhaps we can get them approved without having to wait a few more years for phase 3 to complete.
This also raises the possibility of combinations of treatments such as adding a CTLA-4 inhibitor such as Yervoy and another drug or 2 - perhaps Avastin.
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.nytimes.com/2014/09/05/business/merck-wins-approval-of-novel-immune-system-drug-for-cancer.html?_r=0
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines